Renhe Pharmacy Co.,Ltd (SZSE: 000650)
Health Care · Pharmaceuticals · CN
CN¥5.37
-1.65% today · -18.8% 1Y
Renhe Pharmacy Co.,Ltd (SZSE: 000650) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.11B and employs 4,923 people.
Over the last twelve months the share price has lost 18.8%, trading between 4.85 and 7.02.
Tweenvest scores Renhe Pharmacy Co.,Ltd across four factors: quality 78/100, value 59/100, growth 12/100, dividend 76/100. Its strongest factor is quality.
000650 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.11B
- Revenue (TTM)
- $533.53M
- P/E
- 20.42
- EPS
- 0.26
- Dividend yield
- 2.79%
- Beta (5Y)
- 0.34
- 52-week high
- CN¥7.02
- 52-week low
- CN¥4.85
- Avg volume (3M)
- —
- Shares outstanding
- 1.38B
- Employees
- 4,923
- Next earnings
- —
About Renhe Pharmacy Co.,Ltd
Renhe Pharmacy Co., Ltd. is a pharmaceutical enterprise engaged in the manufacturing and distribution of a wide array of products. Its diverse portfolio includes both traditional Chinese and modern Western medicines, their essential raw materials, and various health and wellness items. These offerings are presented in numerous forms, such as oral solid preparations (e.g., tablets, capsules), liquid medications, large and small volume injectable solutions, topical treatments like lotions, liniments, and ointments, as well as suppositories and other health-related product formats. The company, which was established in 1996, maintains its corporate headquarters in Nanchang, China.
- ISIN
- CNE000000NF8
- Founded
- 1996
- Listed since
- Dec 10, 1996
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,194.90 | -3.14% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.03 | -1.14% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.57 | -1.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.35 | -0.79% |
Figures last refreshed Aug 18, 2026.